0001609351-17-000106.txt : 20170920 0001609351-17-000106.hdr.sgml : 20170920 20170920162712 ACCESSION NUMBER: 0001609351-17-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170919 FILED AS OF DATE: 20170920 DATE AS OF CHANGE: 20170920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faga Daniel CENTRAL INDEX KEY: 0001673528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36819 FILM NUMBER: 171094261 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spark Therapeutics, Inc. CENTRAL INDEX KEY: 0001609351 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462654405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 888-772-7560 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 wf-form4_150593921639753.xml FORM 4 X0306 4 2017-09-19 0 0001609351 Spark Therapeutics, Inc. ONCE 0001673528 Faga Daniel 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 0 1 0 0 Chief Business Officer Common Stock 2017-09-19 4 M 0 1500 37.62 A 1500 D Common Stock 2017-09-19 4 S 0 1500 85 D 0 D Employee Stock Option (right to buy) 37.62 2017-09-19 4 M 0 1500 0 D 2026-05-01 Common Stock 1500.0 137500 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2017. 25% vested May 2, 2017 and the remainder vests in equal quarterly installments over the following three years. /s/ Joseph W. La Barge, attorney-in-fact for Daniel R. Faga 2017-09-20